The Federal Council of Medicine (CFM) has banned the use of PMMA for aesthetic procedures across Brazil starting Tuesday, June 2 [1].
The ban addresses critical safety concerns regarding polymethyl methacrylate, a permanent filler that has been linked to severe health complications and patient deaths [2]. By restricting the substance, the CFM said it aims to prevent further avoidable harm in the country's cosmetic surgery sector [2].
The decision was finalized on May 29 [3]. While the prohibition applies to all cosmetic enhancements, the CFM established a specific exception for the treatment of lipodystrophy in patients living with HIV/AIDS [1].
PMMA is a synthetic polymer used to add volume to the face and body. However, its permanent nature makes it difficult to remove once injected. The CFM said risks to patient health were the primary driver for the nationwide ban [2].
Medical authorities are now focusing on the safety of patients who have already received the filler. The CFM has also requested that the National Health Surveillance Agency (Anvisa) implement a broader ban on the substance [4].
Physicians who violate this regulation face disciplinary action from the medical board. The measure takes effect immediately as of June 2 [1].
“The Federal Council of Medicine (CFM) has banned the use of PMMA for aesthetic procedures across Brazil”
This regulatory shift signals a move toward stricter oversight of permanent fillers in Brazil, prioritizing patient safety over cosmetic demand. By maintaining an exception for HIV/AIDS-related lipodystrophy, the CFM distinguishes between elective aesthetic enhancement and necessary medical treatment for chronic conditions.
